Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 489

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

To: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease

Open access
·2001·Neurology

Abstract

Recently, Yoshida et al. 1 reported a patient who developed fulminant liver failure, requiring urgent liver transplantation, 7 weeks after commencing interferon -1a (Rebif, Serono-Canada, Oakville, Ontario, Canada). The patient received a liver transplant in September 2000 and the authors have received new information that she had been started on nefazodone (Serzone, Bristol-Myers Squibb Canada, Montreal, Quebec) in February of 2000. Nefazodone has recently been reported in association with acute liver failure. The manufacturer of nefazodone has reported 23 cases of liver failure and 109 cases of hepatic adverse events out of 8.3 million users of this drug worldwide. The patient's liver enzymes were stable prior to starting interferon -1a and two-thirds of nefazodone-associated liver failure occurred within 4 months. Interferon -1a appears to be temporally implicated in the patient's liver failure but the authors cannot exclude the possibility that nefazodone may have been a factor or cofactor. The authors regret that they were unaware of this patient's nefazodone use until their paper appeared in print.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.57.11.2153-a

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 489

Metadata

Venue
Neurology
Published
2001-12
Volume
57
Issue
11
Pages
2153-2153
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2775750683
Cited by
489
References
1
FWCI
26.16
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: To: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease. https://app.cochat.ai/papers/10.1212/wnl.57.11.2153-a
The paper
To: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease. (2001). Neurology. https://doi.org/10.1212/wnl.57.11.2153-a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.